Quantitative Relationships between Huntingtin Levels, Polyglutamine Length, Inclusion Body Formation, and Neuronal Death Provide Novel Insight into Huntington's Disease Molecular Pathogenesis

被引:122
作者
Miller, Jason [1 ,2 ,3 ,4 ]
Arrasate, Montserrat [1 ,2 ]
Shaby, Benjamin A. [9 ]
Mitra, Siddhartha [1 ,4 ,6 ]
Masliah, Eliezer [10 ,11 ]
Finkbeiner, Steven [1 ,2 ,5 ,6 ,7 ,8 ]
机构
[1] Univ Calif San Francisco, Gladstone Inst Neurol Dis, San Francisco, CA 94158 USA
[2] Univ Calif San Francisco, Taube Koret Ctr Huntingtons Dis Res, San Francisco, CA 94158 USA
[3] Univ Calif San Francisco, Chem & Chem Biol Program, San Francisco, CA 94158 USA
[4] Univ Calif San Francisco, Med Scientist Training Program, San Francisco, CA 94158 USA
[5] Univ Calif San Francisco, Neurosci Program, San Francisco, CA 94158 USA
[6] Univ Calif San Francisco, Program Biomed Sci, San Francisco, CA 94143 USA
[7] Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94143 USA
[8] Univ Calif San Francisco, Dept Physiol, San Francisco, CA 94143 USA
[9] Duke Univ, Dept Stat Sci, Durham, NC 27708 USA
[10] Univ Calif San Diego, Dept Neurosci, La Jolla, CA 92093 USA
[11] Univ Calif San Diego, Dept Pathol, La Jolla, CA 92093 USA
基金
美国国家卫生研究院;
关键词
CAG REPEAT LENGTH; MUTANT HUNTINGTIN; INTRANUCLEAR INCLUSIONS; CLINICAL PROGRESSION; PREFERENTIAL LOSS; NUCLEAR; AGGREGATION; STRIATUM; NEURODEGENERATION; ABNORMALITIES;
D O I
10.1523/JNEUROSCI.0146-10.2010
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
An expanded polyglutamine (polyQ) stretch in the protein huntingtin (htt) induces self-aggregation into inclusion bodies (IBs) and causes Huntington's disease (HD). Defining precise relationships between early observable variables and neuronal death at the molecular and cellular levels should improve our understanding of HD pathogenesis. Here, we used an automated microscope that tracks thousands of neurons individually over their entire lifetime to quantify interconnected relationships between early variables, such as htt levels, polyQ length, and IB formation, and neuronal death in a primary striatal model of HD. The resulting model revealed that mutant htt increases the risk of death by tonically interfering with homeostatic coping mechanisms rather than producing accumulated damage to the neuron, htt toxicity is saturable, the rate-limiting steps for inclusion body formation and death can be traced to different conformational changes in monomeric htt, and IB formation reduces the impact of the starting levels of htt of a neuron on its risk of death. Finally, the model that emerges from our quantitative measurements places critical limits on the potential mechanisms by which mutant htt might induce neurodegeneration, which should help direct future research.
引用
收藏
页码:10541 / 10550
页数:10
相关论文
共 56 条
[31]   The relationship between CAG repeat length and clinical progression in Huntington's disease [J].
Ravina, Bernard ;
Romer, Megan ;
Constantinescu, Radu ;
Biglan, Kevin ;
Brocht, Alicia ;
Kieburtz, Karl ;
Shoulson, Ira ;
McDermott, Michael P. .
MOVEMENT DISORDERS, 2008, 23 (09) :1223-1227
[32]   DIFFERENTIAL LOSS OF STRIATAL PROJECTION NEURONS IN HUNTINGTON DISEASE [J].
REINER, A ;
ALBIN, RL ;
ANDERSON, KD ;
DAMATO, CJ ;
PENNEY, JB ;
YOUNG, AB .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1988, 85 (15) :5733-5737
[33]   Preferential loss of preproenkephalin versus preprotachykinin neurons from the striatum of Huntington's disease patients [J].
Richfield, EK ;
MaguireZeiss, KA ;
Vonkeman, HE ;
Voorn, P .
ANNALS OF NEUROLOGY, 1995, 38 (06) :852-861
[34]   The association of CAG repeat length with clinical progression in Huntington disease [J].
Rosenblatt, A ;
Liang, KY ;
Zhou, H ;
Abbott, MH ;
Gourley, LM ;
Margolis, RL ;
Brandt, J ;
Ross, CA .
NEUROLOGY, 2006, 66 (07) :1016-1020
[35]   Longitudinal analysis of regional grey matter loss in Huntington disease: effects of the length of the expanded CAG repeat [J].
Ruocco, H. H. ;
Bonilha, L. ;
Li, L. M. ;
Lopes-Cendes, I. ;
Cendes, F. .
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2008, 79 (02) :130-135
[36]   EVIDENCE FOR A PREFERENTIAL LOSS OF ENKEPHALIN IMMUNOREACTIVITY IN THE EXTERNAL GLOBUS-PALLIDUS IN LOW-GRADE HUNTINGTONS-DISEASE USING HIGH-RESOLUTION IMAGE-ANALYSIS [J].
SAPP, E ;
GE, P ;
AIZAWA, H ;
BIRD, E ;
PENNEY, J ;
YOUNG, AB ;
VONSATTEL, JP ;
DIFIGLIA, M .
NEUROSCIENCE, 1995, 64 (02) :397-404
[37]   Huntingtin localization in brains of normal and Huntington's disease patients [J].
Sapp, E ;
Schwarz, C ;
Chase, K ;
Bhide, PG ;
Young, AB ;
Penney, J ;
Vonsattel, JP ;
Aronin, N ;
DiFiglia, M .
ANNALS OF NEUROLOGY, 1997, 42 (04) :604-612
[38]   Huntingtin acts in the nucleus to induce apoptosis but death does not correlate with the formation of intranuclear inclusions [J].
Saudou, F ;
Finkbeiner, S ;
Devys, D ;
Greenberg, ME .
CELL, 1998, 95 (01) :55-66
[39]   Cellular toxicity of polyglutamine expansion proteins: Mechanism of transcription factor deactivation [J].
Schaffar, G ;
Breuer, P ;
Boteva, R ;
Behrends, C ;
Tzvetkov, N ;
Strippel, N ;
Sakahira, H ;
Siegers, K ;
Hayer-Hartl, M ;
Hartl, FU .
MOLECULAR CELL, 2004, 15 (01) :95-105
[40]   Nuclear-targeting of mutant huntingtin fragments produces Huntington's disease-like phenotypes in transgenic mice [J].
Schilling, G ;
Savonenko, AV ;
Klevytska, A ;
Morton, JL ;
Tucker, SM ;
Poirier, M ;
Gale, A ;
Chan, N ;
Gonzales, V ;
Slunt, HH ;
Coonfield, ML ;
Jenkins, NA ;
Copeland, NG ;
Ross, CA ;
Borchelt, DR .
HUMAN MOLECULAR GENETICS, 2004, 13 (15) :1599-1610